UBASH3A: A Potential Drug Target and Biomarker (G53347)

Target Name: UBASH3A

NCBI ID: G53347

UBASH3A

UBASH3A: A Potential Drug Target and Biomarker

Unlike most drugs, UBASH3A is not a small molecule that simply binds to a specific receptor and causes irreversible changes. Instead, it is a protein that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases.

UBASH3A, which stands for Ubiquitous Basic Transmembrane Antigens 3A, is a protein that is expressed in most tissues of the body. It is a member of the superfamily of transmembrane proteins, which are responsible for helping cells maintain their structure and function. UBASH3A is characterized by its unique structure, which consists of a long amino acid sequence that is repeated multiple times in different regions of the protein.

One of the most interesting aspects of UBASH3A is its potential as a drug target. Its unique structure and location in the cell membrane make it an attractive target for drug developers. The fact that UBASH3A is expressed in most tissues of the body also increases its potential as a drug target, as it means that the drug can potentially have a greater impact on a wider range of cells.

In addition to its potential as a drug target, UBASH3A has also been identified as a potential biomarker for various diseases. Its expression has been observed in a variety of diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. This suggests that UBASH3A may be a useful indicator of the severity and progression of these diseases.

UBASH3A's potential as a drug target and biomarker is still in its early stages, and much more research is needed to fully understand its role in disease. However, its unique structure and expression patterns make it an intriguing target for drug developers, and its potential as a biomarker for various diseases makes it an important area of research.

In conclusion, UBASH3A is a protein that has the potential to be a drug target and biomarker for various diseases. Its unique structure and location in the cell membrane make it an attractive target for drug developers, and its expression in most tissues of the body increases its potential as a drug target. Additionally, its potential as a biomarker for various diseases makes it an important area of research. Further research is needed to fully understand its role in disease and its potential as a drug and biomarker.

Protein Name: Ubiquitin Associated And SH3 Domain Containing A

Functions: Interferes with CBL-mediated down-regulation and degradation of receptor-type tyrosine kinases. Promotes accumulation of activated target receptors, such as T-cell receptors, EGFR and PDGFRB, on the cell surface. Exhibits negligigle protein tyrosine phosphatase activity at neutral pH. May act as a dominant-negative regulator of UBASH3B-dependent dephosphorylation. May inhibit dynamin-dependent endocytic pathways by functionally sequestering dynamin via its SH3 domain

The "UBASH3A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about UBASH3A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets